Our goal remains to understand pancreatic beta-cell intermediary and energy metabolism in fuel stimulated insulin secretion and to explore how these processes are modified by neuro-endocrine factors. The focus is on glucose, glutamine and fatty acid metabolism, on the inter connections between the different metabolic pathways and on the fuel dependence of acetylcholine and GLP-1 stimulation of beta-cells. This program continues to be strongly influenced by biochemical genetic information about monogenic hypo- and hyperglycemia syndromes in man, linked to glucokinase, glutamate dehyrogenase, short chain hydoxy acyl-CoA dehydrogenase and SUR-1/Kir6.2. Related pharmacological and therapeutic issues are also considered, e.g. GKAs, SUR-1 inhibitors and GLP-1. We have formulated the following specific projects for the next grant period: 1) Use enzyme kinetics, biophysical techniques including crystallography, pharmacological glucokinase activators, the glucokinase regulatory protein and cell biological approaches to contribute to the comprehensive characterization of normal glucokinase, of glucokinase redesigned by special mutations and of the close to 250 natural mutant glucokinases that cause hypo- or hyperglycemia in man with the twofold goal of explaining the clinical phenotypes and of deepening our understanding of the enzyme's functions including its established glucose sensor role. 2) Apply a broad gamut of approaches including a new method for respirometry, tracer techniques involving radioactive and heavy isotopes, phosphorus-, 13C- and proton NMR and measurements of intracellular calcium to study metabolic pathways of pancreatic islet cells during insulin secretion stimulated by glucose, amino acids and fatty acids (alone or in combination, and also when influenced by neuroendocrine factors) to help elucidate still elusive triggering and amplification mechanisms involved in insulin release. 3) Explore the biochemistry and physiological significance of glucokinase in gonadotropes and thyrotropes of the pituitary gland to help understand the extra-pancreatic and extra-hepatic role of the enzyme.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK022122-32
Application #
7630404
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Appel, Michael C
Project Start
1978-05-01
Project End
2012-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
32
Fiscal Year
2009
Total Cost
$486,906
Indirect Cost
Name
University of Pennsylvania
Department
Biochemistry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Zelent, Bogumil; Raimondo, Anne; Barrett, Amy et al. (2014) Analysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescence. Biochem J 459:551-64
Li, Changhong; Liu, Chengyang; Nissim, Itzhak et al. (2013) Regulation of glucagon secretion in normal and diabetic human islets by ?-hydroxybutyrate and glycine. J Biol Chem 288:3938-51
Zhang, Tingting; Li, Changhong (2013) Mechanisms of amino acid-stimulated insulin secretion in congenital hyperinsulinism. Acta Biochim Biophys Sin (Shanghai) 45:36-43
Prentki, Marc; Matschinsky, Franz M; Madiraju, S R Murthy (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18:162-85
Doliba, Nicolai M; Qin, Wei; Najafi, Habiba et al. (2012) Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab 302:E87-E102
Zelent, B; Buettger, C; Grimsby, J et al. (2012) Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea. Biochim Biophys Acta 1824:769-84
Nissim, Itzhak; Horyn, Oksana; Nissim, Ilana et al. (2012) Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics. Biochem J 444:537-51
Doliba, Nicolai M; Fenner, Deborah; Zelent, Bogumil et al. (2012) Repair of diverse diabetic defects of ?-cells in man and mouse by pharmacological glucokinase activation. Diabetes Obes Metab 14 Suppl 3:109-19
Fenner, Deborah; Odili, Stella; Hong, Hee-Kyung et al. (2011) Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators. J Biol Chem 286:39560-72
Matschinsky, Franz M; Zelent, Bogumil; Doliba, Nicolai et al. (2011) Glucokinase activators for diabetes therapy: May 2010 status report. Diabetes Care 34 Suppl 2:S236-43

Showing the most recent 10 out of 61 publications